Physicians all around the globe have started treating COVID-19 patients with HBOT after finding that five patients in Wuhan. China (2 who were in critical condition and 3 more in severe) were successfully treated. The virus attacks the lungs causing inflammation, therefore the body has a difficult time getting the needed oxygen into the bloodstream. The advantage of using HBOT over the standard ventilators, is that HBOT introduces oxygen to the patient within a higher pressure environment,compensating for the reduced lung capacity and lowering inflammation.
According to the Clinical Trial Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia with COVID-19:NCTO4344431 done by Jean-Eric Blatteau, MD, PhD of Sainte Anne Military Teaching Hospital in Toulon, France
“Several patients with hypoxaemic SARS-CoV-2 pneumonia were able to benefit form hyperbaric oxygen (HBO2) treatment in china. In a clinical case published in the chinese Journal of Hyperbaric Medicine, treatment with repeated HBO2 sessions prevented admission to intensive care unit with mechanical ventilation in a patient aged 69 who presented with signs of respiratory decompensation. HBO2 can dramatically increase the amount of dissolved oxygen in the blood. HBO2 not only promotes blood transport but also its tissue delivery. Furthermore, HBO2 has specific immunomodulatory properties, both humoral and cellular, making it possible, for example, to reduce the intensity of the inflammatory response and to stimulate antioxidant defenses by repeating sessions. A virucidal capacity of HBO2 therapy might also involved”.
TO READ MORE ABOUT THE CLINICAL TRIALS BEING DONE WITH HBOT AND COVID-19
DISCLAIMER: The services provided have not been evaluated by the Food and Drug Administration or CDC for COVID-19. These products are not intended to diagnose, treat, cure or prevent any disease. The material on this website is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any treatment program.